Crystal Structure of the Catalytic Domain of HIV-1 Integrase: Similarity to Other Polynucleotidyl Transferases
The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Abstract
HIV integrase is the enzyme responsible for inserting the viral DNA into the host chromosome; it is essential for HIV replication. The crystal structure of the catalytically active core domain (residues 50 to 212) of HIV-1 integrase was determined at 2.5 Å resolution. The central feature of the structure is a five-stranded β sheet flanked by helical regions. The overall topology reveals that this domain of integrase belongs to a superfamily of polynucleotidyl transferases that includes ribonuclease H and the Holliday junction resolvase RuvC. The active site region is identified by the position of two of the conserved carboxylate residues essential for catalysis, which are located at similar positions in ribonuclease H. In the crystal, two molecules form a dimer with an extensive solvent-inaccessible interface of 1300 Å 2 per monomer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All INs harbour three structural domains connected by flexible linkers: the N-terminal domain (NTD), the catalytic core domain (CCD), and the C-terminal domain (CTD).”
From Structure and function of retroviral integrase (2022) · cites this paper as [23]
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
Free R value: a novel statistical quantity for assessing the accuracy of crystal structures
Brünger, A. T. (1992) · Nature · doi:10.1038/355472a0 · Cited by 3,873
X-PLOR Version 3.1: A System for X-ray Crystallography and NMR
Brünger, A. T. (1992) · Medical Entomology and Zoology · Cited by 3,424
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
Sparse matrix sampling: a screening method for crystallization of proteins
Jancarik, J., & Kim, S. H. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004430 · Cited by 2,049
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Nucleotide sequence of the AIDS virus, LAV
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., & Alizon, M. (1985) · Cell · doi:10.1016/0092-8674(85)90303-4 · Cited by 1,202
Jacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6320 · Cited by 1,115
Beese, L. S., & Steitz, T. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07917.x · Cited by 1,048
Research works printed but not linked: 5
- CROUCH, R.J., NEW BIOL 2: 771 (1990).
- Crouch, R. J., Nucleases: 211 (1982).
- Doublie, S., Crystallization of Nucleic Acids and Proteins: 311 (1992).
- Otwinowski,, Z., Data Collection and Processing: 56 (1993).
- Sherratt, D., Mobile DNA: 163 (1989).
Cited by
Items 501–600 of 842
Improvement of the crystallizability and expression of an RNA crystallization chaperone
Ravindran, P. P., Heroux, A., & Ye, J. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvr093 · Cited by 17
“Many methods have been applied in protein engineering to enhance the crystallization, including generation of fusion proteins to assist in expression and purification process (13 16) removing flexible or unfolded regions (17) and increasing the solubility of the protein by introducing surface charge residues (18, 19).”
MethodPeptide inhibitors of HIV-1 integrase: From mechanistic studies to improved lead compounds
Maes, M., Levin, A., Hayouka, Z., Shalev, D. E., Loyter, A., & Friedler, A. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.09.053 · Cited by 17
Dlakić, M. (2002) · Protein Science · doi:10.1110/ps.4470102 · Cited by 19
“…belong to a functionally diverse superfamily of polynucleotide transferases whose structurally characterized members include HIV-1 integrase (Dyda et al. 1994), RNase H (Katayanagi et al. 1990), Mu transposase (Rice and Mizuuchi 1995) and Holliday junction resolvase RuvC (Ariyoshi et al.…”
BackgroundUse of CrKα radiation to enhance the signal from anomalous scatterers including sulfur
Kwiatkowski, W., Noel, J. P., & Choe, S. (2000) · Journal of Applied Crystallography · doi:10.1107/s0021889800001175 · Cited by 17
“Crystals of the catalytic domain of HIV-1 integrase (Dyda et al., 1994) were used for this study.”
BackgroundMethodDefining functional regions of the IS903 transposase
Tavakoli, N. P., DeVost, J., & Derbyshire, K. M. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1410 · Cited by 17
Brownian and Essential Dynamics Studies of the HIV-1 Integrase Catalytic Domain
Weber, W., Demirdjian, H., Lins, R. D., Briggs, J. M., Ferreira, R., & McCammon, J. A. (1998) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1998.10508285 · Cited by 18
Mapping target site selection for the non-specific nuclease activities of retroviral integrase
Katzman, M., Sudol, M., Pufnock, J. S., Zeto, S., & Skinner, L. M. (2000) · Virus Research · doi:10.1016/s0168-1702(99)00126-4 · Cited by 18
Parissi, V., Caumont‐Sarcos, A., de Soultrait, V. R., Calmels, C., Pichuantes, S. E., Litvak, S., & Dupont, C.-H. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3416 · Cited by 20
Moreau, K., Faure, C., Verdier, G., & Ronfort, C. (2002) · Archives of Virology · doi:10.1007/s00705-002-0831-5 · Cited by 22
“The structure of the three domains have been determined by X-ray crystallography or nuclear magnetic resonance for IN of HIV-1 and shows that the three domains were found in dimeric forms [10, 17 , 18, 19, 43].”
BackgroundInfluentialBiological and Structural Analyses of New Potent Allosteric Inhibitors of HIV-1 Integrase
Bonnard, D., Rouzic, E. L., Singer, M. R., Yu, Z., Strat, F. L., Batisse, C., Batisse, J., Amadori, C., Chasset, S., Pye, V. E., et al. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00462-23 · Cited by 17
“July 2023 Volume 67 Issue 7 10.1128/aac.00462-23 15 Cocrystallization of BDM-2 with isolated HIV-1 IN CCD. Expression and purification of the HIV-1 IN CCD F185K (50-212) were performed as previously described (12) and used for crystallization.”
BackgroundMethodInfluentialRui, E., de Moura, P. R., & Kobarg, J. (2001) · Virus Research · doi:10.1016/s0168-1702(00)00245-8 · Cited by 16
Identification of promoter-binding proteins of the fbp A and C genes in Mycobacterium tuberculosis
Romero, I., Mehaffy, C., Burchmore, R., Dobos, K. M., Brennan, P. J., & Walker, J. (2009) · Tuberculosis · doi:10.1016/j.tube.2009.10.001 · Cited by 16
Araújo, A. R., Ribeiro, A. J. M., Fernandes, P. A., & Ramos, M. J. (2014) · Journal of Chemical Theory and Computation · doi:10.1021/ct500570g · Cited by 16
A Versatile and Practical Synthesis toward the Development of Novel HIV‐1 Integrase Inhibitors
Rinaldi, M., Tintori, C., Franchi, L., Vignaroli, G., Innitzer, A., Massa, S., Esté, J. A., Gonzalo, E., Christ, F., Debyser, Z., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201000510 · Cited by 18
Treatment of HIV infection with raltegravir
Chirch, L. M., Morrison, S. A., & Steigbigel, R. T. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902911488 · Cited by 18
“Catalytically, the metal ions assist in docking reversetranscribed DNA into a site in the nuclear (acceptor) DNA of a target cell [7].”
BackgroundDiamond, T. L., & Bushman, F. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15376-15387.2005 · Cited by 18
“do this, we introduced the D116N and/or S119A substitutions into either 1-212 or 50-288 partners and then asked whether the determinant of target site selection was active in the catalytic (50-288) or the noncatalytic (1-212) background.”
BackgroundMethodInfluentialYang, F., & Roth, M. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9561-9570.2001 · Cited by 20
Yang, F., León, Ó., Greenfield, N. J., & Roth, M. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1809-1817.1999 · Cited by 19
Williams, S., & Essex, J. W. (2009) · Journal of Chemical Theory and Computation · doi:10.1021/ct800162v · Cited by 16
ORF157 from the Archaeal VirusAcidianusFilamentous Virus 1 Defines a New Class of Nuclease
Goulet, A., Piña, M., Redder, P., Prangishvili, D. A., Vera, L., Lichière, J., Leulliot, N., TILBEURGH, H. V., Ortiz-Lombardı́a, M., Campanacci, V., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01664-09 · Cited by 15
“Other members of the polynucleotidyltransferase superfamily include HIV-1 (13) and ASV (10) integrases, RNase H type 1 and 2 (12, 21, 34), the transposase MuA of the bacteriophage Mu (45), and the most distantly related member of this family, the Holliday junction resolvase RuvC from E. coli (3).”
BackgroundDevelopment of HIV-1 integrase inhibitors: recent molecular modeling perspectives
Su, M., Tan, J., & Lin, C. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.012 · Cited by 16
Non-Enzymatic Functions of Retroviral Integrase: The Next Target for Novel Anti-HIV Drug Development
Masuda, T. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00210 · Cited by 22
Mass spectrometry-based footprinting of protein–protein interactions
McKee, C. J., Kessl, J. J., Norris, J. O., Shkriabai, N., & Kvaratskhelia, M. (2008) · Methods · doi:10.1016/j.ymeth.2008.10.023 · Cited by 20
Gavin, D. K., Young, S. M., Xiao, W., Temple, B. R. S., Abernathy, C. R., Pereira, D. J., Muzyczka, N., & Samulski, R. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9433-9445.1999 · Cited by 16
Screening and Optimization Methods for Nonautomated Crystallization Laboratories
Bergfors, T. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-209-0_7 · Cited by 15
“One of many examples where this has worked is HIV-1 integrase (12).”
BackgroundYoshikawa, M., Iwasaki, H., Kinoshita, K., & Shinagawa, H. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00371.x · Cited by 15
“Analysis of the RuvC structure also reveals a topological similarity of its central domain containing the active centre with RNase H, and catalytic domains of HIV-1 integrase and MuA transposase (Ariyoshi et al. 1994; Dyda et al. 1994; Rice & Mizuuchi 1995).”
BackgroundIntegrase of Mason–Pfizer monkey virus
Snášel, J., Krejčík, Z., Jenčová, V., Rosenberg, I., Ruml, T., Alexandratos, J. N., Gustchina, A., & Pichová, I. (2004) · FEBS Journal · doi:10.1111/j.1432-1033.2004.04386.x · Cited by 15
Li, W., Chang, F.-C., & Desiderio, S. V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3935-3946.2001 · Cited by 16
“Direct participation of the DDE motif residues in metal binding has been demonstrated for the human immunodeficiency virus and avian sarcoma virus integrases by crystallographic analysis (5, 12) and for TnsB of Tn7 by the observation that cysteine substitution results in altered metal specificity (38).”
BackgroundFermandjian, S., Maroun, R. G., Amekraz, B., & Jankowski, C. K. (2001) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.231 · Cited by 15
Su, J., Li, Y., Shaw, N., Zhou, W., Zhang, M., Xu, H., Wang, B., & Liu, Z. (2010) · Protein & Cell · doi:10.1007/s13238-010-0045-7 · Cited by 14
“A number of proteins like integrases (Dyda et al., 1994), transposases (Rice and Mizuuchi, 1995), and resolvases (Ariyoshi et al.”
BackgroundNomura, Y., Masuda, T., & Kawai, G. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj085 · Cited by 16
Lu, G., Villa, J. A., Donlin, M. J., Edwards, T. C., Cheng, X., Heier, R. F., Meyers, M. J., & Tavis, J. E. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.09.009 · Cited by 14
“This large family of proteins includes the retroviral RNaseHs and integrases, including the HIV enzymes (Dyda et al., 1994).”
BackgroundShintani, M., Nojiri, H., Yoshida, T., Habe, H., & Omori, T. (2003) · Biotechnology Letters · doi:10.1023/a:1025079027730 · Cited by 14
“In addition, the integrase core domain motifs (Dyda et al. 1994) were found in ORF2 and ORF8 products (data not shown), which mediate integration of a DNA copy of the viral genome into the host chro-”
BackgroundDeveloping G-quartet oligonucleotides as novel anti-HIV agents: focus on anti-HIV drug design
Jing, N. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.8.1777 · Cited by 14
Purification of Untagged Retroviral Integrases by Immobilized Metal Ion Affinity Chromatography
Asante‐Appiah, E., Merkel, G. W., & Skalka, A. M. (1998) · Protein Expression and Purification · doi:10.1006/prep.1997.0818 · Cited by 15
McClure, M. A. (1999) · Elsevier eBooks · doi:10.1016/b978-012220360-2/50009-x · Cited by 15
Reznikoff, W. S. (2007) · doi:10.1128/9781555817954.ch18 · Cited by 14
Steinrigl, A., Nosek, D., Ertl, R., Günzburg, W. H., Salmons, B., & Klein, D. (2007) · Virology · doi:10.1016/j.virol.2006.11.037 · Cited by 13
“Structural analysis suggests that these three acidic residues are in close proximity to each other in the threedimensional form (Bujacz et al., 1995, 1996; Dyda et al., 1994; Jenkins et al., 1995).”
BackgroundGenetic Diversity and Low Therapeutic Impact of Variant-Specific Markers in HIV-1 Pol Proteins
Troyano-Hernáez, P., Reinosa, R., & Holguín, Á. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.866705 · Cited by 16
Imamichi, T., Bernbaum, J. G., Laverdure, S., Yang, J., Chen, Q., Highbarger, H., Hao, M., Sui, H., Dewar, R. L., Chang, W., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01323-21 · Cited by 12
“4%, final structures (PDB entries 2ITG [65], 1B9D [66], and 1ITG [44]) were identified as the templates of CCD with identity of 99.”
BackgroundTargeting Ribonucleases with Small Molecules and Bifunctional Molecules
Borgelt, L., & Wu, P. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00191 · Cited by 13
Crystal Structure of a Metal Ion-bound IS200 Transposase
Lee, H. H., Yoon, J., Kim, H. S., Kang, J. Y., Kim, K. H., Kim, D., Ha, J. Y., Mikami, B., Yoon, H. J., & Suh, S. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511567200 · Cited by 13
Nowak, M. G., Sudol, M., Lee, N. E., Raup‐Konsavage, W. M., & Katzman, M. (2009) · Virology · doi:10.1016/j.virol.2009.04.014 · Cited by 13
“Because this amino acid contributes to the short alpha-helix-2 in crystals of each protein (Bujacz et al., 1995; Dyda et al., 1994), we expect that results fromeither systemwill be relevant to both proteins.”
BackgroundLee, I., & Harshey, R. M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg499 · Cited by 13
Kulkosky, J., Bouhamdan, M., Geist, A., & Pomerantz, R. J. (1999) · Virology · doi:10.1006/viro.1998.9544 · Cited by 13
Moreau, K., Faure, C., Violot, S., Gouet, P., Verdier, G., & Ronfort, C. (2003) · Virology · doi:10.1016/j.virol.2003.09.037 · Cited by 18
“Both IN core domains are dimeric and are composed of 5 h strands and either six (HIV IN) or five (ALSV IN) a helices (Bujacz et al., 1995, 1996; Chen et al., 2000; Dyda et al., 1994; Goldgur et al., 1998; Lubkowski et al., 1998a, 1999; Wang et al., 2001; Yang et al., 2000).”
BackgroundThe complexities of genome analysis, the Retroid agent perspective
McClure, M. A. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.2.79 · Cited by 13
“The second domain of the IN protein is the core region that contains three motifs that conserve the canonical DDE residues of the polynucleotidyl transferases (Figure 3, motifs 2–4) (Dyda et al., 1994).”
BackgroundHaniford, D. B. (2007) · Wiley eBooks · doi:10.1128/9781555817954.ch20 · Cited by 13
Li, M., Li, Z., Chen, X., Cui, Y., Engelman, A. N., & Craigie, R. (2024) · Viruses · doi:10.3390/v16071166 · Cited by 12
“The catalytic core domain (CCD, 59–202) contains the catalytic triad DDE motif (D64, D116, E152) and has a fold shared by many polynucleotidyl transferases [13].”
BackgroundSelf-citationModeling the HIV-1 Intasome: A Prototype View of the Target of Integrase Inhibitors
Yin, Z., & Craigie, R. (2010) · Viruses · doi:10.3390/v2122777 · Cited by 13
“Although it is well over a decade since the structures of all three domains of HIV-1 integrase were determined [4–7], the first structure of a retroviral intasome—that of prototype foamy virus (PFV)—has only recently been solved [8].”
BackgroundSelf-citationEilers, G., Gupta, K., Allen, A., Montermoso, S., Murali, H., Sharp, R. B., Hwang, Y., Bushman, F. D., & Duyne, G. D. V. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011097 · Cited by 11
Structural Basis of Mos1 Transposase Inhibition by the Anti-retroviral Drug Raltegravir
Wolkowicz, U. M., Morris, E. R., Robson, M. I., Trubitsyna, M., & Richardson, J. M. (2014) · ACS Chemical Biology · doi:10.1021/cb400791u · Cited by 13
“1,2 The mechanism of DNA transposition is closely related to the integration of retroviruses, such as human immunode fi - ciency virus 1 (HIV-1).”
BackgroundInfluentialDiscovery of an HIV integrase inhibitor with an excellent resistance profile
Pryde, D. C., Webster, R., Butler, S. L., Murray, E. J., Whitby, K., Pickford, C., Westby, M., Palmer, M. J., Bull, D. J., Vuong, H. V., et al. (2013) · MedChemComm · doi:10.1039/c3md00014a · Cited by 12
Discovery of novel integrase-LEDGF/p75 allosteric inhibitors based on a benzene scaffold
Sugiyama, S., Iwaki, T., Tamura, Y., Tomita, K., Matsuoka, E., Arita, S., Seki, T., Yoshinaga, T., & Kawasuji, T. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115643 · Cited by 13
The Tn 3 -family of Replicative Transposons
Nicolas, É., Lambin, M., Dandoy, D., Galloy, C., Nguyen, N., Oger, C. A., & Hallet, B. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch32 · Cited by 21
Mechanisms of DNA Transposition
Hickman, A. B., & Dyda, F. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch25 · Cited by 15
Self-citationSite-specific Photo-cross-linking between λ Integrase and Its DNA Recombination Target
Kovach, M. J., Tirumalai, R. S., & Landy, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108197200 · Cited by 12
Kanaya, E. N., & Kanaya, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19853 · Cited by 12
Villanueva, R. A., Jonsson, C. B., Jones, J. L., Georgiadis, M. M., & Roth, M. J. (2003) · Virology · doi:10.1016/s0042-6822(03)00559-2 · Cited by 13
Calmels, C., de Soultrait, V. R., Caumont, A., Desjobert, C., Faure, A., Fournier, M., Tarrago-Litvak, L., & Parissi, V. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh298 · Cited by 18
Donzella, G. A., León, Ó., & Roth, M. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1691-1698.1998 · Cited by 13
“The crystal and solution structures of the N-terminal HHCC (containing zinc), central catalytic core, and C-terminal subdomains of IN have substantiated the dimeric nature of these subdomains independent of DNA (5, 7, 15, 33).”
BackgroundThe Integrase: An Overview of a Key Player Enzyme in the Antiviral Scenario
Renzi, G., Carta, F., & Supuran, C. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512187 · Cited by 12
“organization for the entire IN enzyme [12].”
BackgroundInfluentialDinh, T., Tber, Z., Rey, J. S., Mengshetti, S., Annamalai, A. S., Haney, R., Briganti, L., Amblard, F., Fuchs, J. R., Cherepanov, P., et al. (2024) · mBio · doi:10.1128/mbio.00465-24 · Cited by 14
Structural Insights on Retroviral DNA Integration: Learning from Foamy Viruses
Lee, G.-E., Mauro, E., Parissi, V., Shin, C., & Lesbats, P. (2019) · Viruses · doi:10.3390/v11090770 · Cited by 11
“The crystal structure of HIV-1 IN CCD showed a nucleotidyltransferase fold, which is shared with several prokaryotic and eukaryotic transposases, recombinases, and resolvases [30,31].”
BackgroundThe HIV-1 Integrase C-Terminal Domain Induces TAR RNA Structural Changes Promoting Tat Binding
Rocchi, C., Louvat, C., Miele, A. E., Batisse, J., Guillon, C., Ballut, L., Lener, D., Negroni, M., Ruff, M., Gouet, P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213742 · Cited by 14
“The CCD harbors the essential catalytic triad Asp, Asp, Glu (D,D,E) that coordinates two Mg2+ cofactors and folds similarly to nucleotidyl-transferases and nucleases [13].”
BackgroundInsight into the molecular mechanism of the transposon-encoded type I-F CRISPR-Cas system
Alalmaie, A., Diaf, S. R., & Khashan, R. (2023) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-023-00507-8 · Cited by 12
Influence of the amino-terminal sequence on the structure and function of HIV integrase
Eilers, G., Gupta, K., Allen, A., Zhou, J. O., Hwang, Y., Cory, M., Bushman, F. D., & Duyne, G. D. V. (2020) · Retrovirology · doi:10.1186/s12977-020-00537-x · Cited by 11
HIV Virions as Nanoscopic Test Tubes for Probing Oligomerization of the Integrase Enzyme
Borrenberghs, D., Thys, W., Rocha, S., Demeulemeester, J., Weydert, C., Dedecker, P., Hofkens, J., Debyser, Z., & Hendrix, J. (2014) · ACS Nano · doi:10.1021/nn406615v · Cited by 13
Chi, G., Nair, V., Семенова, Е. А., & Pommier, Y. G. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.009 · Cited by 11
Hobaika, Z., Zargarian, L., Maroun, R. G., Mauffret, O., Burke, T. R., & Fermandjian, S. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0098-2 · Cited by 14
“1 Dimer structure of IN-CCD obtained by X-ray crystallography [9].”
Adaptive HIV-1 evolutionary trajectories are constrained by protein stability
Olabode, A. S., Kandathil, S. M., Lovell, S. C., & Robertson, D. L. (2017) · Virus Evolution · doi:10.1093/ve/vex019 · Cited by 11
“HIV-1 protein structures were obtained from the Protein Data Bank (Berman et al. 2002) with the following data information: protease, PDB code 1KZK (Reiling et al. 2002); reverse transcriptase, PDB code 1RTJ (Esnouf et al. 1995); integrase, PDB code 1ITG (Dyda et al. 1994).”
Faust, E. A., & Triller, H. (2002) · Journal of Biomedical Science · doi:10.1007/bf02256074 · Cited by 16
“Human immunodeficiency virus type i (HIV-1) integrase is classically described as a homodimer consisting of 32-kD subunits whose core domain crystal structure has features in common with other polynucleotide strand transferases and RNase H [ 13 , 22].”
BackgroundThe HIV integrase catalytic core
Plasterk, R. H. A. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0295-87 · Cited by 11
Inhibitors of human immunodeficiency virus integration
Hazuda, D. J., & Young, S. D. (2003) · Advances in antiviral drug design · doi:10.1016/s1075-8593(03)04002-4 · Cited by 11
Soluble expression, purification and characterization of the full length IS2 Transposase
Lewis, L. A., Astatke, M., Umekubo, P. T., Alvi, S., Saby, R., & Afrose, J. (2011) · Mobile DNA · doi:10.1186/1759-8753-2-14 · Cited by 11
“The three-dimensional structure of this unit, the catalytic core, has been demonstrated in several members of the TPase/RISF, including the TPases of the DDE family, such as Mu [64] and Tn5 [67], the integrases, such as HIV-1 [68-71] and the avian (ASV) and Rous (RSV) Sarcoma viruses [72,73] and other nucleases, for e…”
BackgroundPeters, J. E. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch30 · Cited by 10
Crystallization of biological macromolecules for X-ray diffraction studies
Gilliland, G. L., & Ladner, J. E. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80024-8 · Cited by 10
Structure‐based design of AIDS drugs and the development of resistance
Wlodawer, A. (2002) · Vox Sanguinis · doi:10.1111/j.1423-0410.2002.tb05261.x · Cited by 10
Berger, N., Heller, A., Störmann, K. D., & Pfaff, E. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-1-139 · Cited by 12
“Complementation experiments (Engelman et al., 1993 ; Van Gent et al., 1993) and X-ray structure analysis of the central domain (Dyda et al., 1994 ; Wlodawer, 1999) strengthen this one-step assumption.”
BackgroundAn Unusual Helix Turn Helix Motif in the Catalytic Core of HIV-1 Integrase Binds Viral DNA and LEDGF
Merad, H., Porumb, H., Zargarian, L., René, B., Hobaika, Z., Maroun, R. G., Mauffret, O., & Fermandjian, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004081 · Cited by 10
“1a) is organized around a two fold axis with a large interface involving, in particular, helices a1 and a5 (residues 172– 184) [18,30].”
BackgroundEbina, H., Chatterjee, A. G., Judson, R. L., & Levin, H. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801354200 · Cited by 9
A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor
Nakamura, T., Nakamura, T., Amano, M., Miyakawa, T., Yamagata, Y., Matsuoka, M., & Nakata, H. (2020) · Journal of Virology · doi:10.1128/jvi.00486-20 · Cited by 9
“F185K substitution by crystallographic analysis (8, 14, 31).”
MethodRole of Transportin-SR2 in HIV-1 Nuclear Import
Tabasi, M., Nombela, I., Janssens, J., Lahousse, A. P., Christ, F., & Debyser, Z. (2021) · Viruses · doi:10.3390/v13050829 · Cited by 11
“HIV-1 integrase is the enzyme responsible for insertion of viral cDNA into the host genome [28].”
BackgroundDing, L., Huang, H., Lu, F., Lu, J., Zhou, X., Zhang, Y., & Cai, M. (2021) · Journal of Industrial Microbiology & Biotechnology · doi:10.1093/jimb/kuab073 · Cited by 8
“Helitron transposase does not contain RNase-H catalytic domain but with helicase domain and HUH endonuclease domain (Dyda et al., 1994; Kapitonov & Jurka, 2001; Grabundzija et al., 2016).”
BackgroundWalker, M. A., Johnson, T., Ma, Z., Zhang, Y., Banville, J., Rémillard, R., Plamondon, S., Pendri, A., Wong, H., Smith, D., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.075 · Cited by 10
Park, J.-H., Yun, J.-H., Shi, Y., Han, J., Li, X., Jin, Z., Kim, T., Park, J., Park, S., Liu, H., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081943 · Cited by 11
“HIV-1 IN-CCD was expressed and purified following the previously described methods [20] Briefly, TRX-hexa-his tagged IN-CCD was expressed in E.”
MethodChon, H., Tadokoro, T., Ohtani, N., Koga, Y., Takano, K., & Kanaya, S. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05241.x · Cited by 9
Raup‐Konsavage, W. M., Sudol, M., & Katzman, M. (2008) · Virology · doi:10.1016/j.virol.2008.07.001 · Cited by 11
Integrase anchors viral RNA to the HIV-1 capsid interior
Singer, M. R., Li, Z., Rey, J. S., Hope, J., Chenavier, F., Cook, N., Punch, E. K., Smith, J., Zhou, Z., Maslen, S., et al. (2026) · Nature · doi:10.1038/s41586-026-10154-x · Cited by 11
“The stoichiometry of retroviral IN complexes follows an empirical 2 N rule: the minimal IN complex is a dimer, mediated by a symmetric interaction of CCDs 41 .”
Self-citationA new functional role of HIV-1 integrase during uncoating of the viral core
Briones, M. S., & Chow, S. A. (2010) · Immunologic Research · doi:10.1007/s12026-010-8164-z · Cited by 12
Protein Crystallography in Drug Discovery
Hogg, T., & Hilgenfeld, R. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00111-5 · Cited by 10
Explanatory Chapter: Troubleshooting Protein Expression
Duong‐Ly, K. C., & Gabelli, S. B. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-420119-4.00018-5 · Cited by 12
Ammendola, S., Politi, L., & Scandurra, R. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00530-4 · Cited by 8
Sirous, H., Zabihollahi, R., Aghasadeghi, M. R., Sadat, S. M., Saghaie, L., & Fassihi, A. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1289-1 · Cited by 10
“These residues bind two divalent metal cofactors which are required for catalytic activity (Dyda et al., 1994; Neamati et al., 2002).”
Li, Y., Yan, Y., Zugay-Murphy, J., Xu, B., Cole, J. L., Witmer, M. V., Felock, P. J., Wolfe, A. L., Hazuda, D. J., Sardana, M. K., et al. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444999009610 · Cited by 8
Ohtsubo, E., MINEMATSU, H., TSUCHIDA, K., Ohtsubo, H., & Sekine, Y. (2004) · Advances in Biophysics · doi:10.1016/s0065-227x(04)80121-7 · Cited by 8
Functional Analysis of N-Terminal Residues of Ty1 Integrase
Moore, S. P., & Garfinkel, D. J. (2009) · Journal of Virology · doi:10.1128/jvi.00159-09 · Cited by 10
“For HIV IN mapping, the multimerization domain is not straightforward, as all three domains assume a dimer conformation in solution (17, 20, 21, 38, 52).”
BackgroundAzzi, S., Parissi, V., Maroun, R. G., Eid, P., Mauffret, O., & Fermandjian, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0016001 · Cited by 8
“Mg2+ or Mn2+) - embedded in an RNase fold [11,12,13,14,15,16,17,18,19].”
BackgroundHIV-1 Integrase Drug Discovery Comes of Age
Demeulemeester, J., Maeyer, M. D., & Debyser, Z. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_33 · Cited by 9
The determination of CHARMM force field parameters for the Mg2+ containing HIV-1 integrase
Musyoka, T. M., Bishop, Ö. T., Lobb, K. A., & Moses, V. (2018) · Chemical Physics Letters · doi:10.1016/j.cplett.2018.09.019 · Cited by 8
Metadata
- Authors
- Dyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1994-12-23
- Volume
- 266
- Issue
- 5193
- Pages
- 1981-1986
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2006572311
- Cited by
- 810
- References
- 73
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 11 · 2023: 11 · 2022: 11 · 2021: 8 · 2020: 8 · 2019: 8 · 2018: 14 · 2017: 16 · 2016: 15 · 2015: 27 · 2014: 27 · 2013: 28 · 2012: 19
- FWCI
- 39.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV-1 integrase, catalytic domain, crystal structure, RNase H, RuvC, Holliday junction resolvase, viral DNA integration, HIV replication
- MeSH terms
- Amino Acid Sequence, Binding Sites, Crystallization, DNA Nucleotidyltransferases, Hydrogen Bonding, Models, Molecular, Molecular Sequence Data, Solubility, HIV-1, Virus Integration, Ribonuclease H, Protein Structure, Secondary, Protein Folding, Crystallography, X-Ray, Integrases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.